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STAT3, these results could not be observed. In vivo results demonstrated that
after surgery of hindlimb ischemia, mice (n¼12) treated with JI-34 pretreated
MSC, MSC and PBS revealed a signiﬁcantly difference of limb recovery and
rebuildment of newly formed vessels. Ultrasound Doppler displayed that mice
injected with treated cells gained a better recovery of blood perfusion in day 3
after surgery and sustained to day14 than MSC and PBS group. Immunoﬂuo-
rescence of CD31, a-SMA, TUNEL and immunohistochemistry also supported
the results that treated with JI-34, MSC increased vascularation and angio-
genesis of mice hindlimb ischemia.
Conclusions: the agonist of GHRH can activate the receptor of MSC to enhance its
viability and paracrine effect through STAT3 signaling pathway to promote the
angiogenesis of ischemic hindlimb of mice.
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Targeted Delivery of Hydrogen Sulﬁde Using Ultrasound and Intravenous
Microbubbles Attenuates Myocardial Ischemia-reperfusion Injury
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Yan Wang, Shuxin Shen, Xinzhong Li, Juefei Wu
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Objectives: Myocardial ischemia-reperfusion injury is a major cause of cardiac
damage following revascularization in acute myocardial infarction. Hydrogen Sulﬁde
(H2S) has emerged as a critical signaling molecule with a profound cardioprotective
effect. However, systemic delivery of H2S is hampered by cytotoxicity. We hypoth-
esized that intravenous administration of microbubbles encapsulating H2S gas com-
bined with ultrasound exposure permit safe and local release of H2S and attenuate
myocardial ischemic-reperfusion injury.
Methods: A 1:1 mixture of the H2S (4ml) and perﬂuorocarbons (4ml) was encap-
sulated into microbubbles (H2S-MB), while microbubbles containing 8ml of
perﬂuorocarbons (PESDA) served as control. Wistar rats were subjected to tempo-
rary ligation of the left coronary artery for 45min. H2S-MB or PESDA were
administered intravenously 5min prior to reperfusion for 10min with or without
ultrasound applied over the heart. H2S concentrations were measured in plasma and
tissue homogenate (heart, lung, kidney and brain) by methylene blue assay. Infarct
size was determined by evans blue and TTC staining. Serum levels of the cardiac-
speciﬁc isoform of troponin-I (cTnI) were assessed 4h after reperfusion. Left ven-
tricular structure and function was assessed by echocardiography 3 weeks after
reperfusion.
Results: Intravenous H2S-MB administration in combination with the ultrasound
exposure enhanced the concentrations of H2S in the myocardial and lung tissue
(P<0.05). Rats receiving H2S-MB and ultrasound representing a signiﬁcant reduction
in infarct size and serum levels of cTnI as compared with PESDA and ultrasound
treated rats (28.02.6% vs 44.64.5%, P¼0.005; 7.61.5 ng/ml vs 13.32.0 ng/ml,
P¼0.019, respectively). There were signiﬁcant differences in ejection fraction between
H2S-MB group and PESDA group both treated with ultrasound exposure (48.61.5%
vs 41.02.0%, P¼0.006). No signiﬁcant hemodynamic differences between H2S-MB
and PESDA were observed.
Conclusions: Targeted delivery of H2S using ultrasound and intravenous micro-
bubbles limits the extent of myocardial ischemia-reperfusion injury. This may provide
a noninvasive strategy for targeted delivery of a therapeutic gas to protect myocardial
injury from ischemia–reperfusion, avoiding systemic side effects.
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Vasomotor effect of salidroside on rat mesenteric artery and its regulatory
mechanisms
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Objectives: To observe vasomotor effect of salidroside (SAL) on rat mesenteric ar-
tery, and to explore its underlying regulatory mechanisms.
Methods: Tension was measured by DMT 610M system to evaluate the vasomotor
effect of SAL on rat endothelium-intact and endothelium-denuded mesenteric artery
rings. L-NAME, an inhibitor of nitric oxide synthase (NOS), indomethacin, a
Cyclooxygenase (COX) inhibitor, calcium deprivation and calcium addition were
used to illustrate the mechanisms of vasomotor effect of SAL.
Results: ① SAL (10-8mol/L - 10-4 mol/L) neither had signiﬁcant effect on mesenteric
artery rings keeping the basic state nor ones precontracted by KCl (610-2mol/L)
(P>0.05).② SAL relaxed endothelium-intact and endothelium-denuded mesenteric
artery precontracted by phenylephrine (210-6mol/L) in concentration-dependent
manner, while the vasodilation of endothelium-intact mesenteric artery was signiﬁ-
cantly stronger than that of endothelium-denuded one (P<0.01 in 10-5 mol/L SAL
and P<0.001 in 10-4 mol/L SAL). ③ Pretreatment with L-NAME (10-4mol/L), for
30min signiﬁcantly attenuated the vasodilation of endothelium-intact mesenteric
artery induced by SAL (P<0.01 in 10-5mol/L SAL), while pretreatment with indo-
methacin (10-4mol/L), for 30 min had no effect on the vasodilation of endothelium-
intact mesenteric artery induced by SAL (P>0.05). ④ With calcium deprivation and
calcium addition, SAL relaxed endothelium-denuded mesenteric artery precontracted
by phenylephrine (210-6mol/L) (P<0.01 in 10-5 mol/L SAL), while SAL had no
effect on the increasing tension of mesenteric artery induced by adding CaCl2
(P>0.05).JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BConclusions: These results indicate that SAL has endothelium-dependent relax-
ation effect on rat mesenteric artery, which might be related to the endothelial
nitric oxide (NO) pathway and inhibiting release of intracelluar calcium of rat
mesenteric artery. However, this vasodilation effect of SAL is not associated
with voltage-dependent calcium channel, the COX pathway and inﬂux of
extracellular calcium.
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Change and trend of the reperfusion injury salvage kinase and mitochondrial
permeability transition pore after ischemic postconditioning in myocardial
ischemia-reperfusion in rats
Xiao Jun
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Objectives: To explore the dynamic variance of the reperfusion injury salvage kinase
and mitochondrial permeability transition pore after ischemic postconditioning in
myocardial ischemia-reperfusionon in rats.
Methods: Lewis rats were randomly assigned to a ischemia-reperfusion or ischemic
postconditioning or sham operation protocol. All groups except sham operation group
underwent myocardial ischemia obtained by ligating anterior descending (LAD)
branch for 30min, and followed by 3, 6, 12, 24-hour and 2, 4, 7-day reperfusion
respectively.In ischemic postconditioning group, three cycles of 10s reperfusion fol-
lowed by 10s LAD re-occlusion were applied during the ﬁrst min of reperfusion. the
expression of P-AKT and P-ERK1/2 protein were mearsured by western blot, and
Spectrophotometer was used to determined the opening of mPTP at the end of the
reperfusion respectively.
Results: Compared with sham operation group, the expression of P-AKT and
P-ERK1/2 protein and the opening of mPTP increased (P<0.01) in both ischemia-
reperfusion group and ischemic postconditioning group at 3, 6, 12, 24-hour and 2, 4,
7-day reperfusion. Compared with ischemia-reperfusion group, the expression of
P-AKT and P-ERK1/2 protein increased (P<0.05), the opening of mPTP decreased
(P<0.05) in ischemic postconditioning group. In both ischemia-reperfusion group and
ischemic postconditioning group, no change in the trend of the expression of P-AKT
and P-ERK1/2 protein and the opening of mPTP, and the peak-time of expression of
P-AKT and P-ERK1/2 protein and the trough-time of opening of mPTP happened at
24h reperfusion.
Conclusions: Ischemic postconditioning increases the expression of P-AKT and
P-ERK1/2 protein, decreases the opening of mPTP between 3 hours and 7 days after
the reperfusion followed myocardial ischemia in rats. However, ischemic post-
conditioning does not change the trend in the expression of P-AKT and P-ERK1/2
protein and the opening of mPTP in ischemia-reperfusionon rats.
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Electrophysiological study of the mechanism of action of the Traditional Chinese
Medicine compound TMYX on the spontaneous activity of cardiac pacemaker
cells
Paina Manuel1, Wang Yi2, Bucchi Annalisa1, Barbuti Andrea1, Wang Yan Yan2,
Sheng Liu3, Yang Jin4, Baruscotti Mirko1, DiFrancesco Dario1
1Department of Biosciences, University of Milan, 2Tian Jin University of Traditional
Chinese Medicine, 3Department of Physiology and Pathophysiology, Tian Jin Medical
University, 4Le Ren Tang Pharmaceutical Factory, Tianjin Zhongxin Pharmaceutical
Group Co. Ltd
Objectives: Traditional Chinese Medicine (TCM) is one of the oldest organized
healing systems in the human history. The TCM approach to the disease differs from
that of western medicine since it is based on the holistic view of both the diseased
state and the associated therapy; modern western medicine focusses instead on the
identiﬁcation and treatment of speciﬁc molecular causes. Both approaches have a
long history of proven results. We therefore started a collaborative project to
investigate the molecular effects of a TCM drug (Tong Mai Yang Xin, TMYX, Le
Ren Tang, China) which is indicated in the treatment of brady- and tachy-arrhyth-
mias. The speciﬁc aim was to investigate whether this drug acts on the sinoatrial
node (SAN).
Methods: Experiments were carried out in cells isolated from rabbit SAN. The
whole-cell patch-clamp technique was used to record the spontaneous activity of
SAN myocytes in the absence and in the presence of TMYX. Based on the in-vitro
toxicity MTT test carried out on a cardiac cell line (H9C2) and on pilot electro-
physiological experiments, we chose to investigate the action of the drug in the
concentration range 0.02-2 mg/ml. The drug was dissolved in dimethyl sulfoxide
(DMSO) and therefore an appropriate amount of DMSO was also added to the
control solution. Action Potentials (AP) were acquired from regularly beating
single cells or cell-aggregates and analyzed by a customized software. Group
comparisons were carried out by paired t-test statistic (statistical signiﬁcance at
P<0.05).
Results: Stable spontaneous APs were recorded from SAN cells/aggregates before
and during perfusion of TMYX. The parameters that describe the properties of each
AP cycle were the following: 1) AP Rate, Maximum Diastolic Potential (MDP), Early
Diastolic Depolarization (EDD), Take-Off Potential (TOP), AP Duration at 50% of
repolarization (APD50). Speciﬁc details are provided in (1).
When SAN cells were challenged with 3 different concentrations (0.02, 0.2, and
0.6 mg/ml) of TMYX we observed in all cases a signiﬁcant (P<0.05) dose-dependentasic and Translational Medicine C67
reduction of rate (-6.9%, -10.1%, and -15.9%) and of the EDD (-9.7%, -20.5%,
-23.2%, respectively, n¼ 4-7) while no differences were observed in the TOP.
MDP and APD values were signiﬁcantly different from control only at the 0.6 mg/ml
dose; in particular APD increased by +15.7% (n¼7) and MDP became less
negative by -6.9% (4.0 mV, n¼7).The time course of the spontaneous rate decrease
proceeded with time constants of 18.4 s, 17.6 s, and 14.2 s for 0.02, 0.2, and 0.6 mg/
ml (n¼4-7), respectively. The effect of the drug was reversible upon wash-out all
concentrations.
Conclusions: Our preliminary experiments provide the ﬁrst evidence that TMYX,
a drug largely used in the treatment of cardiac arrhythmias in TCM, acts as a dose-
dependent spontaneous rate-lowering agent in SAN cells. These preliminary data also
indicate that at doses of 0.2 mg/ml or less, the chronotropic effect reﬂects a selective
action on the early diastolic “pacemaker” depolarization, and thus suggests an effect
on the If current. Since TMYX is a mixture of several pure compounds, we intend to
proceed with the identiﬁcation of the speciﬁc molecule (s) responsible for its chro-
notropic the action.
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Estrogen inhibits cardiac hypertrophy via upregulation of B-type natriuretic
peptide expression in primary neonatal cardiomyocytes
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Objectives: The main purpose of this study was to determine whether estrogen could
regulate cardiac B-type natriuretic peptide (BNP) expression and to examine signal
transduction pathway (s) that are involved in this process. The role of estrogen-
induced BNP expression in estrogen’s anti-hyperthrophic effect will be also investi-
gated in this study.
Methods: BNP expression and related signal pathway of neonatal rat ventricular
cardiomyocytes (NRVCs) under estrogen treatment (E2, 0.1nMw10nM) was
analyzed by real-time quantitative PCR, Western-blotting or immunoﬂuorescence.
Phenylephrine (PE) -induced cardiac hypertrophy under estrogen with or without BNP
neutralizing antibody treatment was indicated by immunostain of cardiac troponin I
and real-time quantitative PCR detection of cardiac hypertrophic markers.
Results: Our results conﬁrmed that estrogen treatment induced both cardiac BNP
mRNA transcription (1.890.18 fold vs control, n¼4, P<0.05) and protein
translation (glycosylated proBNP, 3.930.38 fold vs control ; non-glycosylated
proBNP, 1.780.29 fold vs control, n¼4, P<0.05) in a concentration-dependent
manner. Compared with control group, a higher percentage (63.312.2% vs
18.55.8%, n¼3, P<0.01) of BNP expression positive NRVCs was also observed
in estrogen treatment group, as indicated by BNP immunostaining. Our data also
shown that upregulation of BNP expression under estrogen treatment was
accompanied by Akt (2.100.16 fold vs control n¼3, P<0.01) and p38
(1.870.39 fold vs control, n¼3, P<0.05) phosphorylation but not Erk1/2.
Treatment of PI3-kinase/Akt inhibitor LY294002 or p38 MAPK inhibitor
SB203580 decreased the estrogen-induced BNP expression in NRVCs (P<0.05).
Furthermore, while E2 treatment signiﬁcantly reduced PE induced cardiomyocytes
hypertrophy (cell-surface area, PE 2.170.36 fold vs PE+E2; beta-MHC mRNA,
PE 1.760.10 fold vs PE+E2; alpha-Actin mRNA, PE 1.700.21 fold vs PE+E2,
n¼4, P<0.05), BNP speciﬁc neutralizing antibody partially reversed the ability of
estrogen to block phenylephrine-induced cell size enlargement (cell-surface area,
PE+E2+antiBNP vs PE, P>0.05) and hypertrophic marker gene upregulation (beta-
MHC mRNA, alpha-Actin mRNA, PE+E2+antiBNP mRNA, PE+E2+antiBNP vs
PE, P>0.05) in NRVCs.
Conclusions: Our study shows that estrogen enhances intracellular BNP expression in
primary cardiomyocytes. Both PI3-kinase/Akt and p38 MAPK signal pathways were
involved in estrogen-induced BNP expression. Further, our data suggests that BNP
partially mediates estrogen’s anti-hypertrophic effect on cardiomyocytes. Our study
helps to explain the higher BNP level observed in normal cycling women than men
and offers an insight into estrogen-mediated cardioprotection.
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Connexin 43 in Dendritic Cells NIE Wencheng, 5
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Objectives: Angiotensin II contributes to atherogenesis and plaque vulnerability, but
the mechanisms are not fully understood. Dendritic cells are vital in both inﬂammation
and atherogenesis. To study the relationships between angiotensin II, dendritic cells,
and atherosclerosis, we investigated the effects of angiotensin II on the expression of
connexin43 in dendritic cells.
Methods: Treatment with angiotensin II increased connexin43 expression
(P<0.05) and enhanced the induction of connexin43 expression by lipopoly-
saccharide in mouse bone marrow-derived dendritic cells (P<0.05). TheC68 JACC Vol 64/16/Suppl C j Octobpro-atherogenesis effect, were attenuated by the angiotensin II type 1 receptor
blocker valsartan.
Results: In atherosclerotic plaques of mice expressing high levels of endogenous
angiotensin II ApoE-/-, generated by the 2kidney-1clip method, connexin43
expression in dendritic cells was also increased (P<0.01), accompanied by the
upregulation of the dendritic cell maturation marker CD40 (P<0.01) and vulnerable
plaque phenotypes. The in vitro and in vivo effects of angiotensin II on connexin43
expression, as well as the proatherogenesis effect, were attenuated by the angiotensin
II type 1 receptor blocker valsartan.
Conclusions: Angiotensin II may promote atherosclerosis and plaque vulnerability
by increasing the expression of connexin43 in dendritic cells and inducing the
maturation of dendritic cells through the angiotensin II type 1 receptor, thus altering
the inﬂammatory balance in favor of T helper 1 polarization.
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The Ligament of Marshall: a conduit between left stellate ganglion and ventricle
as well as a target for treating long QT syndrome induced by cesium chloride
Wang Songyun, Hong Jiang
Renmin Hospital of Wuhan University
Objectives: Histology and electrophysiology show that the ligament of Marshall
(LOM) is richly innervated by sympathetic and parasympathetic nerves in humans and
animals. However, the effect of LOM ablation on cardiac autonomic nervous system
and ventricular electrophysiology is still unknown. To explore it, we investigate the
impact of LOM ablation on left stellate ganglion (LSG) stimulation induced blood
pressure and ventricular electrophysiology changes as well as cesium chloride (Cs)
induced ventricular arrhythmias.
Methods: In 24 anesthetized mongrel dogs, a left thoracotomy exposed the LSG
and LOM. Step 1: In 6 dogs, the maximal systolic blood pressure percent
change (MSBP%) and ventricular effective refractory period (ERP) change
induced by LSG stimulation were measured before and after LOM ablation. Step
2: 18 dogs were assigned into two groups: the control group (N¼9) and the
LOM ablation group (N¼9). Cs-induced ventricular arrhythmias were recorded
and the concentration of Cs required to induce ventricular tachycardia was
measured.
Results: LOM ablation could markedly attenuate the increase in the MSBP%
and the decrease in ventricular ERP induced by LSG stimulation (P<0.05).
During 50V LSG stimulation, the MSBP% before and after LOM ablation were
54.32% and 26.96%, respectively (P¼0.003). Compared to the control group,
the incidence of Cs-induced ventricular arrhythmias could be signiﬁcantly
decreased and the concentration of Cs required to induce ventricular tachycardia
was signiﬁcantly elevated in the LOM ablation group (1.25 vs 0.75mmol/kg,
P¼0.002).
Conclusions: Ventricular electrophysiology changes induced by LSG stimulation
could be attenuated by LOM ablation. In Cs-induced LQTS model, LOM ablation
could signiﬁcantly decrease the incidence of ventricular arrhythmias and increase the
ventricular tachycardia susceptibility. LOM may act as a conduit between left stellate
ganglion and ventricle as well as a target for treating Cs-induced LQTS.
GW25-e2116
The effects of local cardiac sympathetic ablation on ventricular electrical
instability after acute myocardial infarction
Jingjie Li, Jugang Chen, Xiuli Wu, Rui Jiang
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Objectives: Increased sympathetic activation after acute myocardial infarction (AMI)
is thought to contribute to the potential for fatal arrhythmia. However, whether local
cardiac sympathetic ablation can reduce ventricular arrhythmias (VA) is not known.
The aim of this study was to investigate the impact of the coronary sinus (CS) and
great cardiac vein peripheral nerve ablation on ventricular electrical instability in acute
myocardial infarction dogs.
Methods: Twenty one anesthetized dogs were randomly divided into sham group
(n ¼5) or MI group (MI-placebo group n¼8; MI-ablation group n¼8).The dogs were
ligated with left anterior descending branch for MI induction. The incidence and
duration of VA were monitored for 1h in 1h after ablation. The ventricular effective
refractory period (VERP) and spatial distribution of refractory periods were measured
before creating MI and in 2 h after ablation. Subsequently the ventricular ﬁbrillation
threshold (VFT) was determined in the dogs without spontaneous VF. Finally, the
tissues from around CS and great cardiac vein were removed and indicating nerve by
immumohistochemical staining of tyrosine hydroxylase (TH). Norepinephrine levels
in Coronary Sinus and ventricle tissues Stores as well as infarct size were also
detected during the experiment. The other groups were the same as the MI-ablation
group.
Results: The incidence and duration of VA in MI-ablation group were signiﬁ-
cantly lower than that MI-placebo group (P<0.05), two dogs in only MI-placebo
group died of spontaneous VF. Before creating MI, there were no statistical
differences in the VERP and spatial distribution of refractory periods between
the three groups, whereas the ventricular ERP of infarct size were prolonged
obviously and spatial distribution of refractory periods were decreased when
compared with MI-placebo group in 2 h after ablation (P<0.05), VFT also
showed a increased trend (P>0.05). During the experiment, NE levels from CSer 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
